APOE and atherosclerosis: Especially in the setting of diabetes, the protective role of TRAIL against diabetes-related atherosclerosis was demonstrated more than a decade ago in apolipoprotein E knockout mice ApoE (−/−) which were used as an experimental model of atherosclerosis [17,81].